You are here

ORPRO THERAPEUTICS INC

Company Information
Address
12670 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130-3086
United States



Information

UEI: DMFYKL5PQLF3

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis

    Amount: $224,482.00

    SUMMARY Effective management of obstructive pulmonary diseases characterized by thickenedhighly viscoelastic mucus represents a significant unmet medical needespecially in cystic fibrosisCFan inherite ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  2. Mucoadhesive drug conjugates for controlled-release inhalation delivery

    Amount: $228,370.00

    SUMMARY Sustained release of drugs delivered onto mucosal surfaces by oraltopical or inhaled routes can be a highly effective means of improving topical bioavailabilityProlongation of epithelial resid ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  3. Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis

    Amount: $1,499,635.00

    SUMMARY Effective management of obstructive pulmonary diseases characterized by thickenedhighly viscoelastic mucus represents a significant unmet medical needespecially in cystic fibrosisCFan inherite ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  4. Development of human thioredoxin as a mucolytic therapy for Cystic Fibrosis

    Amount: $183,089.00

    DESCRIPTION (provided by applicant): Effective management of obstructive pulmonary diseases, especially Cystic Fibrosis (CF), represents a significant unmet medical need. Such diseases are characteriz ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government